SR

Sanjay Ramrao Nimbalkar

Director Director DIN 01355834
DIN 01355834 First appointment Sep 1989 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Sep 1989
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Ramrao Nimbalkar

Data last updated:

Sanjay Ramrao Nimbalkar has 37 years in corporate governance. Formerly with 1 company, such as Geetanjali Pharmaceuticals (India) P. Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 01355834
Primary Designation Director
First Appointment 15 Sep 1989
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Sep 19891989₹5.8 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Geetanjali Pharmaceuticals (India) P. Ltd
Premium access

Shareholding and investment profile for Sanjay Ramrao Nimbalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Ramrao Nimbalkar

Sanjay Ramrao Nimbalkar has 37 years in corporate governance. Formerly with 1 company, such as Geetanjali Pharmaceuticals (India) P. Ltd. Engaged in General Business. Contributes to corporate operations.

Sanjay Ramrao Nimbalkar has expertise in General Business.

Sanjay Ramrao Nimbalkar has 37 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available